Hims & Hers Stock Plummets Despite Major Share Repurchase Initiative

Hims & Hers US4330001060

The telehealth company Hims & Hers Health has seen its share price collapse by 30% over the past month, a stark contrast to the confidence it aimed to project with the announcement of a substantial $250 million stock buyback program. This dramatic sell-off coincides with insider stock sales and occurs while the company’s valuation appears stretched to unprecedented levels, raising significant questions about its current market position.